Management and Outcome of Mesh Infection After Abdominoplasty in a Tertiary Care Centre

Management and Outcome of Mesh Infections After Abdominoplasty in a Tertiary Care Center in France

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06682091

Acronym

MOCOMI

Enrollment

209

Registered

2024-11-12

Start date

2013-01-01

Completion date

2023-01-01

Last updated

2024-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Infection

Keywords

mesh infection, abdominoplasty

Brief summary

Hernia repair is among most frequent surgical interventions. The use of abdominal mesh in hernia repair has become the Gold Standard strategy, reducing the risk of relapse. The mesh infection risk is estimated lower than 1% in simple situations, but can increase up to 20% in complicated patients. Risk factors are well known, but we lack data regarding the therapeutic strategies and outcomes. This study aims to describe the characteristics and management of abdominal mesh infections, and the related outcomes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* parietal mesh infection * age \> 18

Exclusion criteria

* Non French speaking patients. * Persons under tutorship or curatorship.

Design outcomes

Primary

Measure	Time frame	Description
Treatment failure.	Retrospective analysis from initial treatment to any treatment failure within 2010 to 2023	Clinical failure = persistance of the infection. Time of failure is the time of change of therapeutic strategy.

Countries

France

Outcome results